Hospital Pharmacy - July/August 2017 - 507

Gibson et al.
References
1. McCarthy M. US drug costs are rising faster than overall health
spending, officials report. BMJ. 2016;352:i1485.
2. Sodium Nitroprusside. Redbook Online [online database].
Greenwood Village, CO: Truven Health Analytics; 2017.
3. Levine GN, Bates ER, Blankenship JC, et al. 2011 ACCF/
AHA/SCAI guideline for percutaneous coronary intervention:
a report of the American College of Cardiology Foundation/
American Heart Association Task Force on Practice
Guidelines and the Society for Cardiovascular Angiography
and Interventions. J Am Coll Cardiol. 2011;58:e44-e122.
4. Hueb W, Lopes NH, Gersh BJ, et al. Five-year follow-up of
the Medicine, Angioplasty, or Surgery Study (MASS-II).
Circulation. 2007;115:1082-1089.
5. Boos CJ, Anderson RA, Lip GYH. Is atrial fibrillation an
inflammatory disorder? Eur Heart J. 2006;27:136-149.
6. Haas CE, LeBlanc JM. Acute postoperative hypertension:
a review of therapeutic options. Am J Health Syst Pharm.
2004;61:1661-1675.
7. Granger DN. Ischemia-reperfusion: mechanisms of microvascular dysfunction and the influence of risk factors for cardiovascular disease. Microcirculation. 1999;6:167-178.
8. Halpern NA, Goldberg M, Neely C, et al. Postoperative hypertension: a multicenter, prospective, randomized comparison
between intravenous nicardipine and sodium nitroprusside.
Crit Care Med. 1992;20(12):1637-1643.
9. Aronson S, Dyke CM, Stierer KA, et al. The ECLIPSE trials:
comparative studies of clevidipine to nitroglycerin, sodium
nitroprusside, and nicardipine for acute hypertension treatment in cardiac surgery patients. Anesth Analg. 2008;107:
1110-1121.
10. Mathew JP, Fontes ML, Tudor IC, et al. A multicenter risk
index for atrial fibrillation after cardiac surgery. JAMA. 2004;
291(14):1720-1729.
11. Cavoli R, Kaya K, Aslan A, et al. Does sodium nitroprusside
decrease the incidence of atrial fibrillation after myocardial revascularization? A pilot study. Circulation. 2008;118:476-481.
12. Cheungpasitporn W, Thongpraoon C, Kittanamongkolchai
W, et al. Comparison of renal outcomes in off-pump versus
on-pump coronary artery bypass grafting: a systematic review
and meta-analysis of randomized controlled trials. Nephrology.
2015;20(10):727-735.
13. Maseda J, Hilberman M, Derby GC, Spencer RJ, Stinson EB,
Myers BD. The renal effects of sodium nitroprusside in postoperative cardiac surgical patients. Anesthesiology. 1981;54:
284-288.
14. Kaya K, Oguz M, Akar AR, et al. The effect of sodium nitroprusside infusion on renal function during reperfusion period
in patients undergoing coronary artery bypass grafting: a prospective randomized clinical trial. Eur J Cardiothorac Surg.
2007;31:290-297.
15. Zahler S, Massoud P, Harte H, Hahnel C, Meisner H, Becker
BF. Acute cardiac inflammatory responses to postischemic
repercussion during cardiopulmonary bypass. Cardiovasc Res.
1999;41:722-730.

507
16. Massoudy P, Zahler S, Becker BF, et al. Evidence for inflammatory responses of the lungs during coronary artery bypass
grafting with cardiopulmonary bypass. Chest. 2001;119(1)
:31-36.
17. Massoudy P, Zahler S, Barankay A, Becker BF, Richter JA,
Meisner H. Sodium nitroprusside during coronary artery
bypass grafting: evidence for an anti-inflammatory action. Ann
Thorac Surg. 1999;67:1059-1064.
18. Massoudy P, Zahler S, Freyholdt T, et al. Sodium nitroprusside
in patients with compromised left ventricular function undergoing coronary bypass: reduction of cardiac proinflammatory
substances. Thorac Cardiovasc Surg. 2000;119:566-574.
19. Sugishita K, Kinugawa K, Simizu T, et al. Cellular basis for
the acute inhibitory effects of IL-6 and TNF-alpha on excitation-contraction coupling. J Mol Cell Cardiol. 1999;31(8):
1457-1467.
20. Freyholdt T, Massoudy P, Zahler S, et al. Beneficial effect
of sodium nitroprusside after coronary artery bypass surgery: pump function correlates inversely with cardiac release
of proinflammatory cytokines. J Cardiovasc Pharmacol.
2003;42:372-378.
21. He G, Yang C. Comparison of nitroprusside and nitroglycerin in
inhibition of angiotensin II and other vasoconstrictor-mediated
contraction in human coronary bypass conduits. Br J Clin
Pharmacol. 1997;44:361-367.
22. Loop FD, Thomas JD. Hypoperfusion after arterial bypass
grafting. Ann Thorac Surg. 1993;56:812-813.
23. He G, Yang C. Comparison of the vasorelaxant effect of nitroprusside and nitroglycerin in the human radial artery in vitro.
Br J Clin Pharmacol. 1999;48:99-104.
24. Powroznyk AVV, Vuylsteke A, Naughton C, et al. Comparison
of clevidipine with sodium nitroprusside in the control of blood
pressure after coronary artery surgery. Eur J Anaesthesiol.
2003;20:697-703.
25. Vecht RJ, Swanson KT, Nicolaides EP, Lennox SC, Gibson
DC. Comparison of intravenous nicardipine and nitroglycerin
to control systemic hypertension after coronary artery bypass
grafting. Am J Cardiol. 1989;64:19H-21H.
26. Singla N, Warltier DC, Gandhi SD, et al. Treatment of acute
postoperative hypertension in cardiac surgery patients: an
Efficacy Study of Clevidipine Assessing Its Postoperative
Antihypertensive Effect in Cardiac Surgery-2 (ESCAPE-2),
a randomized, double-blind, placebo-controlled trial. Anesth
Analg. 2008;107:59-67.
27. Espinosa A, Ripollés-Melchor J, Casans-Francés R, et al.
Perioperative use of clevidipine: a systematic review and metaanalysis. PLoS ONE. 2016;11:e0150625.
28. Weir MR, Aronson S, Avery EG, Pollack Jr CV. Acute kidney
injury following cardiac surgery: role of perioperative blood
pressure control. Am J Nephrol. 2011;33:438-452.
29. Clevidipine. Redbook Online [online database]. Greenwood
Village, CO: Truven Health Analytics; 2017.
30. Cruz JE, Thomas Z, Lee D, et al. Therapeutic interchange of
clevidipine for sodium nitroprusside in cardiac surgery. P T.
2016;41:635-639.

Table of Contents for the Digital Edition of Hospital Pharmacy - July/August 2017